Vol. 30 (2020)
Artículos de Investigación

Clinical late-stage of breast cancer in the state of Jalisco: magnitude and spatial-temporal variations

Antonio Reyna Sevilla
Departamento de Salud PúblicaCentro Universitario de Ciencias de la SaludUniversidad de Guadalajara
Bio
Igor Martín Ramos Herrera
Departamento de Salud Pública, División de Disciplinas para el Desarrollo, Promoción y Preservación de la Salud, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
Bio
Miguel Ernesto González Castañeda
Departamento de Geografía, División de Estudios Históricos y Humanos, Centro Universitario de Ciencias Sociales y Humanidades, Universidad de Guadalajara.
Bio
Alfonso Cruz Ramos
Coordinación de investigación, Instituto Jalisciense de Cancerología, Secretaría de Salud Jalisco
Bio

Published 2020-06-17

How to Cite

Reyna Sevilla, A., Ramos Herrera, I. M., González Castañeda, M. E., & Cruz Ramos, A. (2020). Clinical late-stage of breast cancer in the state of Jalisco: magnitude and spatial-temporal variations. Acta Universitaria, 30, 1–12. https://doi.org/10.15174/au.2020.2487

Abstract

Official records indicate that in Jalisco, Mexico, the diagnosis of breast cancer (BC) in women is usually performed at advanced stages. Using geo-referenced data of patients treated at a third-level hospital, the magnitude and spatial-temporal variation associated with late clinical stage (IIb, IIIa, IIIb, IIIc, IV) by municipality of residence was identified during 2013-2015. The municipalities of Acatic, Atoyac and Zapotlanejo showed an increase in the estimated rate for this period, whose value was 44.6, 17.7 and 19.2 per hundred thousand women older than 20 years of age, respectively. In addition, the risk of late-stage breast cancer increased up to four times and in accordance to the patient’s municipality of residence. The results show the municipalities where it is required to improve the detection and diagnosis of BC and, especially, to guarantee an early treatment for women who reside in the places of higher risk, in compliance with the guidelines established in the NOM 041-SSA2-2011.